Help us improve by filling out our survey!
It takes around 2 minutes of your time and will help us greatly. All responses are anonymous.
Biobank Sweden is not a biobank but a national infrastructure for biobanking where healthcare, academia, industry, and patient organisations collaborate to attain good healthcare and research.
Here on our website you can find information and documents regarding how to access samples in Swedish biobanks for research, method development or clinical trials.
To simplify the process of applying for biobank samples while reducing the number of forms and documents, Biobank Sweden is looking to digitalize the entire application process. We have met with Hanna Fransson, Product Owner of SBR (the Swedish Biobank Registry), who is leading the work of digitalizing the biobank applications. Hello Hanna! How is […]
Read more
The guide “Sample handling in national studies” is now available for download. The guide contains a schematic overview of important steps for studies wishing to collect biobank samples from multiple locations around Sweden. Biobank Sweden’s Sample Service Coordinators have well-established networks and are familiar with the procedures and services, as well as sample and data […]
Read more
After careful considerations, Biobank Sweden’s steering group has decided to remove the form N3. The document has previously been used to report on completed sampling in multi centre studies. It has emerged that these reports constitute an obstacle for both researchers and sponsors, as well as for Regional Biobank Centres (RBCs) and E-biobank managers, who […]
Read more
In these interviews, reseachers share their personal reflections on how biobanks aid research and the development of improved healthcare.
Here you can see our upcoming webinars, conferences, courses and more!
27–28 November 2025
Aula Medica, Karolinska Institutet, Stockholm
27–28 November 2025
Aula Medica, Karolinska Institutet, Stockholm
1 December 2025
Online
By integrating histopathological images, molecular data from large-scale biobanks and registry-based data, Mattias Rantalainen develops advanced AI models to predict cancer outcomes, support clinical decisions, and drive precision medicine forward.
1 December 2025
Online
Then you can search here. Filter the results by choosing pages, documents, news posts or calendar.
